Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

New research moves us one step closer to personalised breast cancer treatment

New research moves us one step closer to personalised breast cancer treatment

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

Celgene receives FDA 'fast track' for Amrubicin in small cell lung cancer after first-line chemotherapy

Laboratory and mouse studies show targeted drug blocks the growth of breast cancer cells that spread to the brain

Laboratory and mouse studies show targeted drug blocks the growth of breast cancer cells that spread to the brain

Reduced dose anthracycline post-breast cancer surgery has no effect on outcome

Reduced dose anthracycline post-breast cancer surgery has no effect on outcome

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

Herceptin and chemotherapy improves response rates without major adverse effects in HER2 breast cancer

Herceptin and chemotherapy improves response rates without major adverse effects in HER2 breast cancer

BMI may serve as prognostic tool for advanced, aggressive breast cancers

BMI may serve as prognostic tool for advanced, aggressive breast cancers

New global study of targeted therapies for breast cancer

New global study of targeted therapies for breast cancer

Docetaxel given after doxorubicin reduces recurrence

Docetaxel given after doxorubicin reduces recurrence

Anthracyclines improve survival in HER2-positive breast cancer patients

Anthracyclines improve survival in HER2-positive breast cancer patients

Targeted therapy and chemotherapy shrinks breast cancer metastases in brain

Targeted therapy and chemotherapy shrinks breast cancer metastases in brain

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

Taxol-type drugs give slight boost to survival rates in early breast cancer

Taxol-type drugs give slight boost to survival rates in early breast cancer